6-oxo-pipecolic acid quantitation by mass spectrometry
Abstract:
Methods for determining the presence or amount of oxopiperidine in a biological sample using mass spectrometry. These methods may be used to efficiently and non-invasively diagnose pyridoxine dependent epilepsy (PDE) due to deficient a-aminoadipic-δ-semialdehyde (α-AASA) dehydrogenase activity due to mutations in ALDH7A1, resulting in the accumulation of Δ1-P6C, P6CH, and 6-Oxo-PIP in biological samples.
Public/Granted literature
Information query
Patent Agency Ranking
0/0